Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vioxx (Rofecoxib) as Palliative Therapy in Disseminated Stomach Cancer
NCT00165048Phase 3Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rofecoxib in gastric cancer (GC), sponsored by The Chinese University of Hong Kong. Status: unknown.
02
Drugs
rofecoxib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00165048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165048.